Free Trial

Heatwurx (PCSA) Competitors

Heatwurx logo
$0.24 +0.03 (+14.31%)
Closing price 04:00 PM Eastern
Extended Trading
$0.24 -0.01 (-2.39%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PCSA vs. LSB, TLPH, DWTX, AEON, NLSP, CLRB, CHRO, KPRX, TSBX, and BMRA

Should you be buying Heatwurx stock or one of its competitors? The main competitors of Heatwurx include LakeShore Biopharma (LSB), Talphera (TLPH), Dogwood Therapeutics (DWTX), AEON Biopharma (AEON), NLS Pharmaceutics (NLSP), Cellectar Biosciences (CLRB), Chromocell Therapeutics (CHRO), Kiora Pharmaceuticals (KPRX), Turnstone Biologics (TSBX), and Biomerica (BMRA). These companies are all part of the "pharmaceutical products" industry.

Heatwurx vs. Its Competitors

LakeShore Biopharma (NASDAQ:LSB) and Heatwurx (NASDAQ:PCSA) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations, valuation and media sentiment.

LakeShore Biopharma's return on equity of 0.00% beat Heatwurx's return on equity.

Company Net Margins Return on Equity Return on Assets
LakeShore BiopharmaN/A N/A N/A
Heatwurx N/A -319.56%-232.40%

In the previous week, Heatwurx had 4 more articles in the media than LakeShore Biopharma. MarketBeat recorded 5 mentions for Heatwurx and 1 mentions for LakeShore Biopharma. Heatwurx's average media sentiment score of 0.73 beat LakeShore Biopharma's score of 0.00 indicating that Heatwurx is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LakeShore Biopharma
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Heatwurx
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Heatwurx has lower revenue, but higher earnings than LakeShore Biopharma.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LakeShore Biopharma$80.82MN/A-$61.09MN/AN/A
HeatwurxN/AN/A-$11.85M-$3.08-0.08

Heatwurx has a consensus target price of $2.00, indicating a potential upside of 723.72%. Given Heatwurx's stronger consensus rating and higher probable upside, analysts clearly believe Heatwurx is more favorable than LakeShore Biopharma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LakeShore Biopharma
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Heatwurx
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

LakeShore Biopharma has a beta of 0.58, meaning that its share price is 42% less volatile than the S&P 500. Comparatively, Heatwurx has a beta of 1.3, meaning that its share price is 30% more volatile than the S&P 500.

52.6% of LakeShore Biopharma shares are held by institutional investors. Comparatively, 91.9% of Heatwurx shares are held by institutional investors. 9.6% of Heatwurx shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Heatwurx beats LakeShore Biopharma on 9 of the 12 factors compared between the two stocks.

Get Heatwurx News Delivered to You Automatically

Sign up to receive the latest news and ratings for PCSA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PCSA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PCSA vs. The Competition

MetricHeatwurxMED IndustryMedical SectorNASDAQ Exchange
Market Cap$2.52M$2.39B$5.50B$8.96B
Dividend YieldN/A1.80%5.25%4.02%
P/E Ratio-0.083.9819.9019.84
Price / SalesN/A771.14436.90127.27
Price / CashN/A161.3437.0657.97
Price / Book0.534.638.125.62
Net Income-$11.85M$31.26M$3.16B$248.50M
7 Day Performance28.81%6.81%4.40%5.54%
1 Month Performance-25.22%4.31%4.09%7.52%
1 Year Performance-85.28%3.88%34.53%22.06%

Heatwurx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PCSA
Heatwurx
3.779 of 5 stars
$0.24
+14.3%
$2.00
+723.7%
-86.8%$2.52MN/A-0.0820Gap Up
High Trading Volume
LSB
LakeShore Biopharma
0.3477 of 5 stars
$0.99
-0.4%
N/AN/A$9.26M$80.82M0.00773News Coverage
Positive News
Gap Up
TLPH
Talphera
1.594 of 5 stars
$0.46
+2.7%
$5.00
+979.9%
-45.9%$9.25M$650K-1.0319Gap Up
DWTX
Dogwood Therapeutics
1.3087 of 5 stars
$4.60
-4.2%
$10.00
+117.4%
N/A$9.17MN/A-0.255
AEON
AEON Biopharma
3.3533 of 5 stars
$0.79
-5.5%
$360.00
+45,371.8%
-98.9%$8.95MN/A4.405
NLSP
NLS Pharmaceutics
N/A$2.27
-7.0%
N/A+1,192.5%$8.78MN/A0.006
CLRB
Cellectar Biosciences
3.2751 of 5 stars
$4.80
flat
$375.00
+7,712.5%
-93.7%$8.69MN/A-0.2210Gap Down
CHRO
Chromocell Therapeutics
N/A$1.34
+6.3%
N/A-87.4%$8.69MN/A-1.084Gap Up
High Trading Volume
KPRX
Kiora Pharmaceuticals
1.7654 of 5 stars
$2.81
-1.4%
$10.00
+255.9%
-35.6%$8.68MN/A-0.9710News Coverage
TSBX
Turnstone Biologics
1.5645 of 5 stars
$0.37
+0.9%
$0.45
+23.3%
-83.9%$8.37MN/A-0.1382
BMRA
Biomerica
0.3815 of 5 stars
$3.40
+4.0%
N/A-7.4%$8.32M$5.41M-1.4760

Related Companies and Tools


This page (NASDAQ:PCSA) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners